Decoy Therapeutics, Inc. — Form D
Decoy Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-28. The offering totals $1.2M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-04-28
- Form: D
- Accession: 0001079973-25-000699
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $1.0M
- Remaining: $180K
- Investors: 16
- Date of first sale: 2025-04-11
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-544648
Issuer
- Name: Decoy Therapeutics, Inc.
- CIK: 0002065438
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1 BROADWAY, CAMBRIDGE, MA, 02142
- Phone: 617-447-8299
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Barbara Klaus Hibner | Director | Cambridge, MA |
| Barbara Klaus Hibner | Executive Officer | Cambridge, MA |
| Frederick Ernest Pierce | Director | Cambridge, MA |
| Frederick Ernest Pierce | Executive Officer | Cambridge, MA |
| Michael Klaus Lipp | Executive Officer | Cambridge, MA |
| Peter Klaus Marschel | Director | Cambridge, MA |
| Peter Klaus Marschel | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More